NO20045483L - Bedring av utviklingen av katarakt og andre oftalmiske sykdommer - Google Patents
Bedring av utviklingen av katarakt og andre oftalmiske sykdommerInfo
- Publication number
- NO20045483L NO20045483L NO20045483A NO20045483A NO20045483L NO 20045483 L NO20045483 L NO 20045483L NO 20045483 A NO20045483 A NO 20045483A NO 20045483 A NO20045483 A NO 20045483A NO 20045483 L NO20045483 L NO 20045483L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- alkenyl
- cataracts
- development
- improvement
- Prior art date
Links
- 208000002177 Cataract Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38128702P | 2002-05-17 | 2002-05-17 | |
PCT/US2003/015948 WO2003096991A2 (en) | 2002-05-17 | 2003-05-19 | Amelioration of the development of cataracts and other opthalmic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045483L true NO20045483L (no) | 2004-12-16 |
Family
ID=29550095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045483A NO20045483L (no) | 2002-05-17 | 2004-12-16 | Bedring av utviklingen av katarakt og andre oftalmiske sykdommer |
Country Status (13)
Country | Link |
---|---|
US (3) | US7442711B2 (es) |
EP (1) | EP1507826A4 (es) |
JP (1) | JP4615309B2 (es) |
KR (1) | KR20060013632A (es) |
CN (1) | CN100469776C (es) |
AU (1) | AU2003243282B2 (es) |
BR (1) | BR0310057A (es) |
CA (1) | CA2484512C (es) |
IL (1) | IL164639A (es) |
MX (1) | MXPA04011416A (es) |
NO (1) | NO20045483L (es) |
WO (1) | WO2003096991A2 (es) |
ZA (1) | ZA200408449B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100469776C (zh) * | 2002-05-17 | 2009-03-18 | 奥特拉控股公司 | 白内障和其它眼病发展的改善 |
US20040057983A1 (en) | 2002-09-25 | 2004-03-25 | David Schmidt | Biomolecular wearable apparatus |
AU2003300471A1 (en) * | 2003-01-03 | 2004-08-10 | Eric F. Bernstein | Methods for treating ocular diseases |
US7589107B2 (en) * | 2003-05-19 | 2009-09-15 | Othera Holding, Inc. | Amelioration of vitrectomy-induced cataracts |
US7825134B2 (en) * | 2003-05-19 | 2010-11-02 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
WO2005051328A2 (en) * | 2003-11-20 | 2005-06-09 | Othera Pharmaceuticals, Inc. | Amelioration of macular degeneration and other ophthalmic diseases |
AU2004296738A1 (en) * | 2003-11-20 | 2005-06-23 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
US20080312283A1 (en) * | 2005-05-26 | 2008-12-18 | Othera Pharmaceuticals, Inc. | Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts |
US20070197599A1 (en) * | 2006-02-02 | 2007-08-23 | Matier William L | Hydroxylamines and derivatives as anti-angiogenic agents |
US20070197593A1 (en) * | 2006-02-22 | 2007-08-23 | Matier William L | Hydroxylamines and derivatives for treatment of inflammatory conditions of the liver |
US20070203190A1 (en) * | 2006-02-22 | 2007-08-30 | Ghanshyam Patil | Hydroxylamines and derivatives for the inhibition of complement activation |
EP2120942A2 (en) * | 2007-02-16 | 2009-11-25 | Othera Holding, Inc. | Drug resistance reversal in neoplastic disease |
EP2620429A1 (en) | 2007-02-22 | 2013-07-31 | Colby Pharmaceutical Company | Hydroxylamine compounds and methods of their use |
US20090253745A1 (en) * | 2007-11-28 | 2009-10-08 | Sirion Therapeutics, Inc. | Modulators of ocular oxidative stress |
US8602961B2 (en) * | 2008-05-15 | 2013-12-10 | Lifewave Products Llc | Apparatus and method of stimulating elevation of glutathione levels in a subject |
BR112012010179A2 (pt) | 2009-10-30 | 2015-09-29 | Nestec Sa | métodos para manter a saúde do olho e melhorar as doenças oftálmicas em caninos. |
US8778969B2 (en) | 2009-11-07 | 2014-07-15 | Peter H Proctor | Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines |
EP2397474A1 (de) * | 2010-06-17 | 2011-12-21 | Construction Research & Technology GmbH | 2-Oxo-1,3-dioxolan-4-carbonsäureester, ihre Herstellung und Verwendung |
US9012647B2 (en) | 2011-04-07 | 2015-04-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders |
EP2514800B2 (de) | 2011-04-21 | 2018-03-07 | Merck Patent GmbH | Verbindungen und flüssigkristallines Medium |
CN104011040B (zh) * | 2011-12-22 | 2017-03-15 | 建筑研究和技术有限公司 | 2‑氧代‑1,3‑二氧戊环‑4‑甲酰胺、其制备方法和用途 |
CN102584683B (zh) * | 2012-02-29 | 2014-12-24 | 中国人民解放军第四军医大学 | Tempol类衍生物的合成及辐射防护作用 |
EP2818465A1 (en) * | 2013-06-26 | 2014-12-31 | Construction Research & Technology GmbH | 2-Oxo-1,3-dioxolane-4-acyl halides, their preparation and use |
US9314457B2 (en) | 2014-06-19 | 2016-04-19 | The University Of Utah Research Foundation | Methods of treating and preventing vascular instability diseases |
PL441664A1 (pl) * | 2022-07-07 | 2024-01-08 | Uniwersytet Warszawski | Nitroksylowa pochodna polifenolu, sposoby jej wytwarzania oraz jej zastosowanie |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3936456A (en) | 1972-03-24 | 1976-02-03 | Ciby-Geigy Corporation | Substituted piperazine dione oxyls and hydroxides and polymer compositions stabilized thereby |
US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
NL188266C (nl) | 1975-07-29 | 1992-05-18 | Merck & Co Inc | Werkwijze ter bereiding van een oogheelkundig inplantaat. |
US4287175A (en) | 1978-06-22 | 1981-09-01 | Merck & Co., Inc. | Contact lens wetting agents |
JPS5899449A (ja) | 1981-12-09 | 1983-06-13 | Sanyo Chem Ind Ltd | カチオン性ビニルモノマ−の安定化法 |
US4404302A (en) | 1982-05-27 | 1983-09-13 | Ferro Corporation | Acylated hindered hexahydropyrimidines and their use as light stabilizing agents |
US4590231A (en) | 1983-10-11 | 1986-05-20 | Ciba-Geigy Corporation | Polyolefin compositions stabilized against degradation using hydroxylamine derivatives |
US5225196A (en) | 1983-11-14 | 1993-07-06 | Columbia Laboratories, Inc. | Bioadhesive compositions and methods of treatment therewith |
US4615697A (en) | 1983-11-14 | 1986-10-07 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
US4983392A (en) | 1983-11-14 | 1991-01-08 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
DE3569514D1 (en) | 1984-03-22 | 1989-05-24 | Ciba Geigy Ag | Process for the preparation of nitroxyls of sterically hindered amines |
US4691015A (en) * | 1984-07-23 | 1987-09-01 | Ciba-Geigy Corporation | Hydroxylamines derived from hindered amines |
US5209927A (en) | 1985-01-23 | 1993-05-11 | Alcon Laboratories, Inc. | Ophthalmic solution |
US4668699A (en) | 1985-08-05 | 1987-05-26 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
JPS6385547A (ja) | 1986-09-29 | 1988-04-16 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−写真感光材料 |
US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
FR2608045B1 (fr) | 1986-12-12 | 1990-03-02 | Chauvin Laboratoires | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome |
US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
EP0309401B2 (en) | 1987-09-21 | 2002-06-05 | Ciba Specialty Chemicals Holding Inc. | Stabilization of coatings with N-hydroxy hindered amines |
EP0309400B1 (en) | 1987-09-21 | 1994-03-02 | Ciba-Geigy Ag | N-acyloxy hindered amine stabilizers |
DE3801790A1 (de) | 1988-01-22 | 1989-07-27 | Resart Ihm Ag | Kunststoffmaterial mit hoher uv-durchlaessigkeit, verfahren zu dessen herstellung und dessen verwendung |
ES2050274T3 (es) | 1988-06-14 | 1994-05-16 | Ciba Geigy Ag | Procedimiento para la estabilizacion fotoquimica de fibras de polipropileno sin teñir y teñidas. |
US5073278A (en) | 1988-07-18 | 1991-12-17 | Ciba-Geigy Corporation | Lubricant composition |
US5004770A (en) | 1988-10-19 | 1991-04-02 | Ciba-Geigy Corporation | Polymeric substrates stabilized with N-substituted hindered amines |
US4927891A (en) | 1988-11-23 | 1990-05-22 | Pennwalt Corporation | Polymer bound light stabilizer coating resins |
US5030243A (en) | 1989-01-05 | 1991-07-09 | Ciba-Geigy Corporation | Process for the photochemical stabilization of undyed and dyeable artificial leather with a sterically hindered amine |
DE4000551A1 (de) | 1989-01-13 | 1990-07-19 | Ciba Geigy Ag | Verfahren zum fotochemischen stabilisieren von gefaerbter wolle |
US5145893A (en) * | 1989-03-21 | 1992-09-08 | Ciba-Geigy Corporation | Non-migrating 1-hydrocarbyloxy hindered amine derivatives as polymer stabilizers |
US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
JPH0331342A (ja) | 1989-06-28 | 1991-02-12 | Mitsubishi Petrochem Co Ltd | ポリオレフィン樹脂組成物 |
DE59010484D1 (de) | 1989-11-08 | 1996-10-10 | Ciba Geigy Ag | Schmierstoffzusammensetzungen |
EP0787492B1 (en) | 1990-03-16 | 2003-09-17 | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE | Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
ATE132366T1 (de) | 1990-05-29 | 1996-01-15 | Boston Ocular Res | Zusammensetzung zur behandlung von dry eye erkrankungen |
ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
KR100193146B1 (ko) * | 1990-07-20 | 1999-06-15 | 월터 클리웨인, 한스-피터 위트린 | 안정화된 단량체 조성물 |
EP0467850B1 (en) | 1990-07-20 | 1995-09-06 | Ciba-Geigy Ag | Stabilized monomer compositions |
US5290888A (en) | 1990-07-20 | 1994-03-01 | Ciba-Geigy Corporation | Process for stabilizing ethylenically unsaturated compounds and stabilized monomer compositions |
JPH04166930A (ja) | 1990-10-31 | 1992-06-12 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
US5475013A (en) | 1990-11-19 | 1995-12-12 | Monsanto Company | Retroviral protease inhibitors |
FR2670517B1 (fr) | 1990-12-13 | 1993-04-09 | Normandie Const Meca | Element de franchissement pour le franchissement d'obstacles. |
US5198130A (en) | 1991-01-08 | 1993-03-30 | Ciba-Geigy Corporation | Lubricant compositions |
US5399473A (en) | 1991-04-12 | 1995-03-21 | Fuji Photo Film Company, Ltd. | Silver halide color photographic material |
JP2681424B2 (ja) | 1991-04-12 | 1997-11-26 | 富士写真フイルム株式会社 | ハロゲン化銀カラー写真感光材料 |
IT1246779B (it) | 1991-04-12 | 1994-11-26 | Ciba Geigy Spa | Composti piperidinici atti all'impiego come stabilizzanti per materiali organici. |
ES2101994T3 (es) | 1992-04-08 | 1997-07-16 | Ciba Geigy Ag | Antioxidantes liquidos como estabilizadores. |
DE4327297B4 (de) | 1992-08-17 | 2007-05-24 | Clariant Finance (Bvi) Ltd. | Verwendung von Piperidinverbindungen |
TW237471B (es) | 1992-09-03 | 1995-01-01 | Ciba Geigy | |
JPH06172592A (ja) | 1992-12-09 | 1994-06-21 | Sumitomo Chem Co Ltd | カーボンブラック含有ポリオレフィン系樹脂組成物 |
US5707643A (en) | 1993-02-26 | 1998-01-13 | Santen Pharmaceutical Co., Ltd. | Biodegradable scleral plug |
CH688878B5 (de) | 1993-04-06 | 1998-11-13 | Ciba Geigy Ag | Handelsformen von sterisch gehindertem Amin und deren Verwendung. |
IT1270975B (it) | 1993-06-03 | 1997-05-26 | Ciba Geigy Spa | Composti piperidin-triazinici atti all'impiego come stabilizzanti allaluce, al calore e alla ossidazione per materiali organici |
DE4320444A1 (de) | 1993-06-21 | 1994-12-22 | Agfa Gevaert Ag | Farbfotografisches Aufzeichnungsmaterial |
IT1264946B1 (it) | 1993-07-16 | 1996-10-17 | Ciba Geigy Spa | Derivati del 2,2,6,6-tetrametil-4-piperidinolo utili come stabilizzanti alla luce ed all'ossidazione per materiali organici. |
IT1264817B1 (it) | 1993-07-28 | 1996-10-10 | Ciba Geigy Spa | Derivati di polialchil-4-piperidinoli atti all'impderivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici iego come stabilizzanti per materiali organici |
EP0638616A1 (de) | 1993-08-13 | 1995-02-15 | Ciba-Geigy Ag | Pigmentsalze |
CA2131047A1 (en) | 1993-09-01 | 1995-03-02 | Takashi Sanada | Thermoplastic resin composition |
GB9318846D0 (en) | 1993-09-10 | 1993-10-27 | Sandoz Ltd | Improvements in or relating to organic compounds |
TW327185B (en) | 1993-09-20 | 1998-02-21 | Ciba Sc Holding Ag | Liquid antioxidants |
AU1447095A (en) | 1993-12-30 | 1995-07-17 | Arcturus Pharmaceutical Corporation | Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways |
EP0665294B1 (de) | 1994-01-19 | 1999-05-19 | Ciba SC Holding AG | Stabilisieren von Leder gegen thermische und photochemische Zersetzung |
US5466233A (en) | 1994-04-25 | 1995-11-14 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
WO1996015110A1 (en) | 1994-11-15 | 1996-05-23 | Moreno Paolini | N-hydroxypiperidines as superoxide radicals scavengers |
US5725493A (en) | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
US5518732A (en) | 1995-02-14 | 1996-05-21 | Chiron Vision, Inc. | Bio-erodible ophthalmic shield |
IT1273607B (it) | 1995-04-26 | 1997-07-08 | Ciba Geigy Spa | Combinazione di stabilizzanti per polimeri sintetici organici |
US5699182A (en) | 1995-05-25 | 1997-12-16 | Xytronyx, Inc. | Light fatigue resistant photochromic formulations |
TW416970B (en) | 1995-05-31 | 2001-01-01 | Ciba Sc Holding Ag | Carrier-bound light stabilizers and antioxidants as fillers and stabilizers |
US5718922A (en) | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation |
US6469057B1 (en) * | 1995-06-02 | 2002-10-22 | Mcw Research Foundation, Inc. | Methods for in vivo reduction of free radical levels and compositions useful therefor |
US5869079A (en) | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
JPH0952975A (ja) | 1995-08-18 | 1997-02-25 | Clariant Internatl Ltd | 顔料の安定化方法及びこの方法に用いる組成物 |
DE19530468A1 (de) | 1995-08-18 | 1997-02-20 | Sandoz Ag | Verwendung von Piperidinverbindungen |
EP0761466B1 (en) | 1995-08-30 | 1999-08-04 | Eastman Kodak Company | Stabilised dye-donor element for use in thermal dye transfer |
US5821374A (en) | 1995-11-21 | 1998-10-13 | Hoffmann-La Roche Inc. | Process for the oxidation of alcohols |
WO1997026879A1 (en) * | 1996-01-26 | 1997-07-31 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health | Hydroxylamine compositions for the prevention or retardation of cataracts |
WO1997039052A1 (en) | 1996-04-12 | 1997-10-23 | Clariant Finance (Bvi) Limited | Stabilization of polyolefins |
GB9607565D0 (en) | 1996-04-12 | 1996-06-12 | Clariant Int Ltd | Stabilizer composition |
DE19618197A1 (de) | 1996-05-07 | 1997-11-13 | Hoechst Ag | Neue sterisch gehinderte Piperidinderivate als Lichtschutzmittel für Polymere |
JPH1045778A (ja) | 1996-07-29 | 1998-02-17 | Sakai Chem Ind Co Ltd | 新規なヒンダードアミン塩及びその用途 |
JPH1045777A (ja) | 1996-07-29 | 1998-02-17 | Sakai Chem Ind Co Ltd | 新規な有機リン化合物及びその用途 |
WO1998027149A1 (en) | 1996-12-19 | 1998-06-25 | Exxon Chemical Patents Inc. | Method of melt processing amine containing polyethylenes |
AU5757098A (en) | 1996-12-20 | 1998-07-17 | Ciba Specialty Chemicals Holding Inc. | Transesterification catalysts fixed to solid support materials |
US6194457B1 (en) * | 1997-01-29 | 2001-02-27 | A. Glenn Braswell | Liquid eye drop composition |
US5981584A (en) | 1997-02-06 | 1999-11-09 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
JPH10219140A (ja) | 1997-02-07 | 1998-08-18 | Nippon Nsc Ltd | 耐候性塗料用樹脂エマルション |
JPH10220381A (ja) | 1997-02-07 | 1998-08-18 | Matsushita Refrig Co Ltd | 密閉型圧縮機 |
DE19816681A1 (de) | 1997-04-18 | 1998-10-22 | Ciba Geigy Ag | Azidhaltige Stabilisatoren |
IT1291599B1 (it) | 1997-04-18 | 1999-01-11 | Great Lakes Chemical Italia | Composti appartenenti alla classe delle enammine e loro utilizzo come antiossidanti per polimeri organici |
IT1302988B1 (it) | 1997-05-08 | 2000-10-18 | Great Lakes Chemical Italia | Polimeri organici stabilizzati alla luce |
CA2295631A1 (en) | 1997-07-23 | 1999-02-04 | Ciba Specialty Chemicals Holding Inc. | Inhibition of pulp and paper yellowing using nitroxides and other coadditives |
DE19735255B4 (de) | 1997-08-14 | 2007-08-23 | Clariant Produkte (Deutschland) Gmbh | Synergistisches Stabilisatorgemisch auf Basis von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen und dessen Verwendung |
US5902598A (en) | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
FR2773165B1 (fr) | 1997-12-26 | 2001-06-08 | Rhodia Chimie Sa | Stabilisation des moules en elastomere silicone |
FR2773320B1 (fr) | 1998-01-05 | 2000-03-03 | Optisinvest | Dispositif pour le transfert intraoculaire de produits actifs par iontophorese |
DE19804910A1 (de) | 1998-02-07 | 1999-08-12 | Clariant Gmbh | Polyolefin-Formmasse zur Herstellung von kalandrierten Folien/Platten |
IT1298452B1 (it) | 1998-02-26 | 2000-01-10 | Great Lakes Chemical Italia | Composizioni fotocromatiche dotate di resistenza a fatica alla luce ed articoli fotocromatici che le contengono |
TWI224995B (en) | 1998-03-19 | 2004-12-11 | Ciba Sc Holding Ag | Stabilization of wood substrates |
US6149925A (en) | 1998-11-05 | 2000-11-21 | Color Access, Inc. | Topical compositions for enhancing glutathione production |
US6433007B1 (en) | 1998-12-17 | 2002-08-13 | Alcon Manufacturing, Ltd. | Methods for the prevention and treatment of post-surgical complications |
US6410045B1 (en) | 1999-02-22 | 2002-06-25 | Clyde Lewis Schultz | Drug delivery system for antiglaucomatous medication |
US6281192B1 (en) | 1999-03-01 | 2001-08-28 | Vista Scientific Llc | Mucin containing ophthalmic preparations |
US6429194B1 (en) | 1999-03-01 | 2002-08-06 | Vista Scientific Llc | Mucin containing ophthalmic preparation |
JP3527435B2 (ja) | 1999-05-21 | 2004-05-17 | ユニ・チャーム株式会社 | 使い捨ておむつ |
TW514581B (en) | 1999-09-02 | 2002-12-21 | Ciba Sc Holding Ag | A method of protecting wood against light-induced degradation by treatment with an impregnation which penetrates the surface of the wood |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US20010036943A1 (en) * | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
AU2001267864A1 (en) | 2000-06-29 | 2002-01-08 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Remedial agent for optic nerve disease and the like |
IT1320080B1 (it) | 2000-10-25 | 2003-11-18 | Giuliani Spa | Composizione per uso farmaceutico o dietetico. |
ES2342594T3 (es) * | 2002-05-02 | 2010-07-09 | Basf Se | Productos estabilizados para el cuidado personal y productos para el hogar. |
CN100469776C (zh) | 2002-05-17 | 2009-03-18 | 奥特拉控股公司 | 白内障和其它眼病发展的改善 |
US7825134B2 (en) | 2003-05-19 | 2010-11-02 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
JP4288302B1 (ja) | 2008-01-18 | 2009-07-01 | トモデータサービス有限会社 | 位置検出装置および位置検出プログラム並びに施設図面データ |
-
2003
- 2003-05-19 CN CNB038112213A patent/CN100469776C/zh not_active Expired - Fee Related
- 2003-05-19 JP JP2004504990A patent/JP4615309B2/ja not_active Expired - Fee Related
- 2003-05-19 US US10/440,583 patent/US7442711B2/en not_active Expired - Fee Related
- 2003-05-19 CA CA2484512A patent/CA2484512C/en not_active Expired - Fee Related
- 2003-05-19 AU AU2003243282A patent/AU2003243282B2/en not_active Ceased
- 2003-05-19 BR BRPI0310057-0A patent/BR0310057A/pt not_active IP Right Cessation
- 2003-05-19 WO PCT/US2003/015948 patent/WO2003096991A2/en active Search and Examination
- 2003-05-19 KR KR1020047018566A patent/KR20060013632A/ko not_active Application Discontinuation
- 2003-05-19 MX MXPA04011416A patent/MXPA04011416A/es active IP Right Grant
- 2003-05-19 ZA ZA200408449A patent/ZA200408449B/xx unknown
- 2003-05-19 EP EP03753107A patent/EP1507826A4/en not_active Withdrawn
-
2004
- 2004-10-17 IL IL164639A patent/IL164639A/en not_active IP Right Cessation
- 2004-12-16 NO NO20045483A patent/NO20045483L/no not_active Application Discontinuation
-
2008
- 2008-06-18 US US12/141,166 patent/US8383648B2/en not_active Expired - Fee Related
-
2012
- 2012-12-21 US US13/723,586 patent/US20130131052A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1507826A4 (en) | 2007-11-07 |
US8383648B2 (en) | 2013-02-26 |
IL164639A (en) | 2012-02-29 |
JP4615309B2 (ja) | 2011-01-19 |
EP1507826A2 (en) | 2005-02-23 |
BR0310057A (pt) | 2007-04-10 |
CN100469776C (zh) | 2009-03-18 |
WO2003096991A3 (en) | 2004-02-26 |
KR20060013632A (ko) | 2006-02-13 |
ZA200408449B (en) | 2007-09-26 |
MXPA04011416A (es) | 2005-09-30 |
CN1653125A (zh) | 2005-08-10 |
US7442711B2 (en) | 2008-10-28 |
CA2484512A1 (en) | 2003-11-27 |
AU2003243282A1 (en) | 2003-12-02 |
CA2484512C (en) | 2013-04-16 |
US20130131052A1 (en) | 2013-05-23 |
US20080274983A1 (en) | 2008-11-06 |
WO2003096991A2 (en) | 2003-11-27 |
AU2003243282B2 (en) | 2008-05-01 |
JP2005527605A (ja) | 2005-09-15 |
IL164639A0 (en) | 2005-12-18 |
US20040002461A1 (en) | 2004-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20045483L (no) | Bedring av utviklingen av katarakt og andre oftalmiske sykdommer | |
ES476496A1 (es) | Procedimiento para preparar derivados de acido ftalazin-4- ilacetico. | |
YU70901A (sh) | Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
HUP0300567A2 (hu) | Eljárás új piperazinszármazékok elżállítására | |
CO5611127A2 (es) | Derivados de indolilmaleimida | |
CY1117132T1 (el) | Παραγωγο θειαζολιου | |
ECSP034574A (es) | Derivados de naftaleno | |
EA200100487A1 (ru) | Производные 2-аминотиазола, способ их получения и применение указанных веществ в качестве противоопухолевых средств | |
EA200501516A1 (ru) | Производные 2,3,6-тризамещённого-4-пиримидона | |
EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
DE69835877D1 (de) | Trizyklische verbindungen | |
HRP20070194T3 (en) | N-thiazol-2-yl-benzamide derivatives | |
DK0791006T3 (da) | Polyanioniske benzylglylcosider som inhibitorer af proliferation af glatte muskelceller | |
WO2008136444A1 (ja) | 縮合複素環誘導体 | |
ES2187261A1 (es) | Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos. | |
PA8573501A1 (es) | Derivados de benzoxazina y su empleo | |
NO20060079L (no) | 6-(1,1-Difluoralkyl)-4-Aminopikolinater og deres anvendelse som Herbicider | |
WO2005055926A3 (en) | Amelioration of cataracts, macular degeneration and other ophthalmic diseases | |
EA200400208A1 (ru) | Фенилацетамидотиазольные производные, способ их получения и их использования в качестве противоопухолевых средств | |
EA200401164A1 (ru) | Фунгицидные триазолопиримидины, способ их получения и их применение для борьбы с фитопатогенными грибами, а также содержащие их средства | |
CO6150165A2 (es) | Nevos derivados 5,7-disustituidos de [1,3]tiazolo[4,5-d]pirimidin-2 (3h)-ona y su uso en terapia | |
MXPA04003278A (es) | Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina. | |
TW350838B (en) | Quinoline derivatives | |
BRPI0306851A2 (pt) | aplicação de derivados de polissacarídeos como substâncias antiinfectantes | |
JO2433B1 (en) | Preparation of heterocyclic lindane landscapes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |